Cancer vaccines: finding the best way to train the immune system.
Goldman
Bruce
B
D000951:Antigens, Neoplasm / Q000276:immunology; D001943:Breast Neoplasms / Q000276:immunology / Q000628:therapy; D019496:Cancer Vaccines / Q000276:immunology* / Q000627:therapeutic use*; D002272:Carcinoembryonic Antigen / Q000276:immunology; D003713:Dendritic Cells / Q000276:immunology*; D005260:Female; D006360:Heat-Shock Proteins / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification*; D006801:Humans; D018396:Mucin-1; D009077:Mucins; D009369:Neoplasms / Q000235:genetics / Q000276:immunology* / Q000628:therapy*; D016133:Polymerase Chain Reaction; D012334:RNA, Neoplasm / Q000302:isolation & purification; D013601:T-Lymphocytes / Q000276:immunology
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D002272:Carcinoembryonic Antigen; D006360:Heat-Shock Proteins; C060192:MUC1 protein, human; D018396:Mucin-1; D009077:Mucins; D012334:RNA, Neoplasm